-
Mashup Score: 5ACR on Air: Deficiency of Adenosine Deaminase 2 (DADA 2) - 3 day(s) ago
Dr. Pui Y. Lee, a pediatric rheumatologist, leading researcher and clinician, joins us today to lend his insights on Deficiency of Adenosine Deaminase 2 or “DADA 2”. What is this disease and how common is it? What is the underlying pathophysiology, the role of genetic screening and the most useful diagnostic tools? We’ll also cover treatment options for DADA 2, the prognosis most patients face, plus the future of research for this condition.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5ACR on Air: Deficiency of Adenosine Deaminase 2 (DADA 2) - 7 day(s) ago
Dr. Pui Y. Lee, a pediatric rheumatologist, leading researcher and clinician, joins us today to lend his insights on Deficiency of Adenosine Deaminase 2 or “DADA 2”. What is this disease and how common is it? What is the underlying pathophysiology, the role of genetic screening and the most useful diagnostic tools? We’ll also cover treatment options for DADA 2, the prognosis most patients face, plus the future of research for this condition.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 9ACR on Air: Campaigning for Rheumatology in An Election Year Legislative & Policy Update - 14 day(s) ago
As 2024 ends, the ACR’s Government Affairs Committee looks ahead to the 119th Congress to address key issues in rheumatology. For our second annual legislative and policy update, we’re joined by Dr. Lennie McDaniel, head of ACR’s Washington DC office, and Dr. Christina Downey, Chair of the Government Affairs Committee, to share insights from their ACR Convergence 2024 session. Topics include Medicare cuts, physician payments, pharmacy benefit managers (PBMs), telemedicine reimbursement changes, and how you can advocate for better outcomes with the ACR.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 9ACR on Air: Campaigning for Rheumatology in An Election Year Legislative & Policy Update - 21 day(s) ago
As 2024 ends, the ACR’s Government Affairs Committee looks ahead to the 119th Congress to address key issues in rheumatology. For our second annual legislative and policy update, we’re joined by Dr. Lennie McDaniel, head of ACR’s Washington DC office, and Dr. Christina Downey, Chair of the Government Affairs Committee, to share insights from their ACR Convergence 2024 session. Topics include Medicare cuts, physician payments, pharmacy benefit managers (PBMs), telemedicine reimbursement changes, and how you can advocate for better outcomes with the ACR.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 7ACR on Air: Campaigning for Rheumatology in An Election Year Legislative & Policy Update - 27 day(s) ago
As 2024 ends, the ACR’s Government Affairs Committee looks ahead to the 119th Congress to address key issues in rheumatology. For our second annual legislative and policy update, we’re joined by Dr. Lennie McDaniel, head of ACR’s Washington DC office, and Dr. Christina Downey, Chair of the Government Affairs Committee, to share insights from their ACR Convergence 2024 session. Topics include Medicare cuts, physician payments, pharmacy benefit managers (PBMs), telemedicine reimbursement changes, and how you can advocate for better outcomes with the ACR.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 21ACR on Air - 30 day(s) ago
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3ACR on Air - 1 month(s) ago
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 10ACR on Air - 1 month(s) ago
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 21ACR on Air - 1 month(s) ago
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3ACR on Air - 1 month(s) ago
As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in twice a month for engaging interviews and commentary.
Source: acronair.libsyn.comCategories: General Medicine News, RheumatologyTweet
Listen in as Dr. Pui Y. Lee breaks down the statistical analysis that shows why he believes deficiency of adenosine deaminase 2 (DADA2) may be more common than previously thought → https://t.co/ianiy27dWP #pedsrheum https://t.co/YuLitumORD